Approvals/CIMA-AEMPS/SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION

Approved

STANDARD

SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8f8c4802bb0218ad
Drug Cima Aemps Name: SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION
Register Number: 1211533003
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2021-05-25
Dosage Form: POLVO PARA INHALACIÓN
Dose: 12,75 microgramos/202 microgramos
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

SALMETEROL XINAFOATO

18,52 µg

FLUTICASONA PROPIONATO

202 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 25, 2021

Approval ID

8f8c4802bb0218ad

Type

Standard